[1]张杰荣,熊时喜,林 超.补肾健骨汤对骨质疏松性腰椎骨折患者骨密度、炎症指标及疼痛程度的影响[J].陕西中医,2023,(12):1717-1721.[doi:DOI:10.3969/j.issn.1000-7369.2023.12.011]
 ZHANG Jierong,XIONG Shixi,LIN Chao.Effects of Bushen Jiangu decoction on bone mineral density,inflammatory indicators and pain degree in patients with osteoporotic lumbar fractures[J].,2023,(12):1717-1721.[doi:DOI:10.3969/j.issn.1000-7369.2023.12.011]
点击复制

补肾健骨汤对骨质疏松性腰椎骨折患者骨密度、炎症指标及疼痛程度的影响
分享到:

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2023年12期
页码:
1717-1721
栏目:
临床研究
出版日期:
2023-12-05

文章信息/Info

Title:
Effects of Bushen Jiangu decoction on bone mineral density,inflammatory indicators and pain degree in patients with osteoporotic lumbar fractures
作者:
张杰荣熊时喜林 超
(三亚市中医院骨一科,海南 三亚 572000)
Author(s):
ZHANG JierongXIONG ShixiLIN Chao
(First Department of Orthopedics,Sanya Traditional Chinese Medicine Hospital,Sanya 572000,China)
关键词:
骨质疏松性腰椎骨折 补肾健骨汤 肾精不足型 骨密度 骨代谢指标 炎症指标
Keywords:
Osteoporotic lumbar fractures Bushen Jiangu decoction Kidney essence insufficiency Bone mineral density Bone metabolism indicators Inflammatory indicators
分类号:
R 683.2
DOI:
DOI:10.3969/j.issn.1000-7369.2023.12.011
文献标志码:
A
摘要:
目的:探究补肾健骨汤对骨质疏松性腰椎骨折患者术后骨密度、炎症指标和疼痛程度的影响。方法:选取肾精不足型骨质疏松性腰椎骨折患者106例,按单双号法随机将患者分为中药组和常规组,各53例。两组患者均行经皮椎体后凸成形术,术后常规组予对症支持治疗,中药组在常规组基础上予补肾健骨汤,两组均治疗12周,随访3个月。比较两组骨折愈合情况、中医症状积分、骨密度、骨代谢指标、疼痛视觉模拟评分(VAS)、Oswestry功能障碍指数(ODI)、炎症指标,记录两组患者治疗期间不良反应。结果:中药组术后下床活动时间、骨折愈合时间明显短于常规组(均P<0.05)。治疗后,两组主症、次症积分下降,且中药组治疗后各项积分低于常规组(均P<0.05)。治疗后,两组血清骨钙素(OST)、骨碱性磷酸酶(BAP)、25羟基维生素D[25(OH)D]水平及骨密度上升,且中药组治疗后上述指标高于常规组(均P<0.05)。治疗后,两组VAS、ODI评分下降,且中药组治疗后评分低于常规组(均P<0.05)。治疗后,两组血清肿瘤坏死因子-α(TNF-α)水平下降,转化生长因子-β1(TGF-β1)、白细胞介素-10(IL-10)水平上升(均P<0.05); 且中药组治疗后上述指标与常规组比较差异有统计学意义(均P<0.05)。两组治疗及随访期间均未出现明显不良反应。结论:补肾健骨汤治疗肾精不足型骨质疏松性腰椎骨折患者可促进术后骨折愈合,减轻疼痛和炎症反应,改善骨密度及骨代谢。
Abstract:
Objective:To explore the effects of Bushen Jiangu decoction on bone mineral density,inflammation index and pain degree of patients with osteoporotic lumbar fracture after operation.Methods:106 patients with osteoporotic lumbar fractures of kidney essence insufficiency were selected and uniformly numbered after admission and randomly divided into traditional Chinese medicine group and conventional group according to odd-even number method,with 53 cases in each group.Both groups of patients received percutaneous kyphoplasty,and the conventional group was given symptomatic support treatment after surgery,the traditional Chinese medicine group was additionally treated with Bushen Jiangu decoction,and both groups were treated for 12 weeks and followed up for 3 months.The fracture healing conditions,traditional Chinese medicine symptoms scores,bone mineral density,bone metabolism indicators,Visual Analogue Scale(VAS),Oswestry Disability Index(ODI)and inflammatory indicators were compared between the two groups,and the adverse reactions during treatment were recorded in both groups.Results:The postoperative ambulation time and fracture healing time in traditional Chinese medicine group were significantly shorter than those in conventional group(all P<0.05).After treatment,the scores of primary and secondary symptoms were decreased in both groups,and the scores were lower in traditional Chinese medicine group than those in conventional group(all P<0.05).Serum levels of osteocalcin(OST),bone alkaline phosphatase(BAP)and 25 hydroxyvitamin D [25(OH)D] and bone mineral density in both groups were increased after treatment,and the above indicators in traditional Chinese medicine group after treatment were higher than those in conventional group(all P<0.05).After treatment,the scores of VAS and ODI in both groups were declined,and the scores after treatment were lower in traditional Chinese medicine group compared to conventional group(all P<0.05).After treatment,serum level of tumor necrosis factor-α(TNF-α)was reduced while the levels of transformation factor-β1(TGF-β1)and interleukin-10(IL-10)were enhanced(all P<0.05),and the above levels in traditional Chinese medicine group were significantly different from those in conventional group after treatment(all P<0.05).There were no obvious adverse reactions in the two groups during treatment and follow-up.Conclusion:Bushen Jiangu decoction is beneficial to promoting the postoperative healing,relieving the pain and inflammatory response,and improving the bone mineral density and bone metabolism in patients with osteoporotic lumbar fractures of kidney essence insufficiency.

参考文献/References:

[1] 程 明,彭诗语,江 娇,等.不同治疗方法对骨质疏松性胸腰椎压缩骨折椎体力学稳定性影响的有限元分析[J].中国修复重建外科杂志,2022,36(12):1519-1523.
[2] 穆佐洲,邵海龙.手术入路对骨质疏松性胸腰椎骨折术后并发症的影响及术后再骨折危险因素分析[J].陕西医学杂志,2022,51(7):848-851,855.
[3] 廖 敏,谭 洁,吉 滔,等.补肾健骨汤对绝经后骨质疏松症患者骨代谢指标及性激素水平影响研究[J].陕西中医,2023,44(6):726-729.
[4] 邱贵兴,裴福兴,胡侦明,等.中国骨质疏松性骨折诊疗指南(骨质疏松性骨折诊断及治疗原则)[J].中华骨与关节外科杂志,2015,8(5):371-374.
[5] 国家食品药品监督管理总局.中药新药临床研究指导原则试行[M].北京:中国医药科技出版社,2002:361-390.
[6] 黄晓东,陈昌红.骨水泥强化椎弓根钉内固定术对老年骨质疏松性胸腰椎骨折的疗效[J].实用医学杂志,2022,38(22):2813-2816,2821.
[7] 刘 辉,饶放萍,熊志鹏,等.高龄骨质疏松性胸腰椎压缩骨折椎体增强术[J].中国矫形外科杂志,2021,29(20):1886-1888.
[8] 吴秀芳,秦 飞,亓 强,等.TEAS联合腰痛宁胶囊治疗原发性骨质疏松症疼痛的效果观察[J].川北医学院学报,2022,37(9):1157-1160.
[9] 何升华,任之强,王 建,等.从血瘀对骨代谢的影响探讨血瘀在女性原发性骨质疏松症发病中的作用机制[J].中国骨质疏松杂志,2017,23(1):69-73,96.
[10] 付 斌,董 毅,丁惠强.浸骨水泥明胶海绵预填注联合骨水泥分次注射对骨质疏松性胸腰椎骨折经皮穿刺椎体后凸成形术术中骨水泥渗漏的影响[J].实用医学杂志,2022,38(22):2828-2831,2837.
[11] 郑春妹,童玉梅,吴 惠,等.骨质疏松患者骨折术后再发骨折的危险因素分析[J].中国卫生统计,2021,38(5):773-774.
[12] 姜益华,徐金渭,熊振飞,等.补肾健骨汤对绝经后骨质疏松性胸腰椎压缩性骨折患者术后疗效的影响[J].中国实用妇科与产科杂志,2022,38(9):950-954.
[13] 杨 旭,王花欣,张 倩,等.六味地黄丸联合密固达对骨质疏松症的临床疗效及生活质量的影响[J].中国实验方剂学杂志,2022,28(14):115-120.
[14] 乔小万,邓 强,李中锋,等.基于“肾虚髓枯”理论探讨骨质疏松症的病机及中药治疗[J].中国骨质疏松杂志,2022,28(5):760-765,780.
[15] 李 勃,刘 凯,范 红,等.补肾健骨汤联合西药治疗老年骨质疏松性胸腰椎压缩性骨折临床研究[J].陕西中医,2018,39(5):625-627.
[16] 徐 晋,戎 洋,杨治斌,等.益肾补骨汤治疗对老年骨质疏松性胸腰椎骨折患者经皮椎体成形术后疼痛、伤椎愈合及腰椎功能的影响[J].解放军医药杂志,2022,34(5):131-134.
[17] 孙家燕,张晓妍.磷酸西格列汀、二甲双胍及阿卡波糖联合应用治疗2型糖尿病伴骨质疏松疗效及对患者糖脂代谢、骨代谢水平的影响[J].陕西医学杂志,2021,50(10):1275-1278.
[18] 陈定中,杨 益,李超艺,等.唑来膦酸联合依降钙素对骨质疏松骨折患者术后骨痛及骨折愈合的影响[J].中国临床药理学杂志,2022,38(16):1863-1867.
[19] 杨 帆,陈 铭,张 强,等.老年骨质疏松性胸腰椎骨折患者血清脂联素与骨密度及骨转换生化指标的相关性[J].中国老年学杂志,2022,42(3):591-594.
[20] 束婷婷.血清25羟维生素D、TRACP-5b、PINP、β-CTX在绝经期骨质疏松病人中的检测意义[J].实用老年医学,2022,36(12):1273-1276.
[21] 侯 娜,孙晓娟.枸杞提取物对骨质疏松症大鼠的改善作用[J].现代食品科技,2019,35(11):37-44,108.
[22] 许 勇,谢贤斐,薛 彬,等.川续断提取皂甙促进骨质疏松模型中骨髓基质细胞成骨分化的作用机制研究[J].现代生物医学进展,2022,22(3):401-406.
[23] 李绍烁,赵京涛,何昌强,等.山茱萸总甙干预骨质疏松模型大鼠骨代谢:TRPV6、TRPV5通路的变化[J].中国组织工程研究,2019,23(11):1749-1754.
[24] 林洁华,周颖燕,徐侦雄,等.熟地寄生壮骨方对大鼠创伤性骨关节炎模型抗炎及保护软骨作用的实验研究[J].中国中医基础医学杂志,2017,23(3):411-414.
[25] 孙群周.狗脊多糖通过miR-181c调控IL-1β介导的骨关节炎软骨细胞增殖和凋亡[J].中国老年学杂志,2021,41(11):2398-2402.
[26] 廖 锋,刘 瑶,刘航航,等.当归多糖对高糖状态下大鼠骨髓间充质干细胞成骨向分化的影响[J].华西口腔医学杂志,2019,37(2):193-199.
[27] 杨旭峰,郝彦明,陆 轲,等.炎性骨髓微环境影响骨质疏松发生发展的机制研究[J].中国骨质疏松杂志,2022,28(11):1614-1619.
[28] 李智奎,孔俊博,赵王林.补肾活血方辅助治疗对绝经后骨质疏松患者炎性因子及骨代谢指标的影响[J].中国老年学杂志,2020,40(9):1901-1904.
[29] 周 峰,高一淋.血清网膜素-1、转化生长因子-β1、铁蛋白水平对胸腰椎骨质疏松性骨折内固定术后骨不愈合的预测价值[J].实用医学杂志,2022,38(21):2715-2719.
[30] 吴晓燕,厉 星.木香烃内酯通过抑制NLRP3缓解LPS诱导小鼠巨噬细胞的炎症反应[J].中国免疫学杂志,2019,35(12):1433-1437.
[31] 闫 安,谢云亮.当归多糖对脑缺血再灌注损伤大鼠脑组织氧化应激水平及炎症因子表达的影响[J].中国实验方剂学杂志,2018,24(2):123-127.
[32] 陈 磊,张 莉.续断对骨质疏松性骨折大鼠炎症因子的影响[J].中国骨质疏松杂志,2019,25(11):1619-1622.
[33] 李朋月,景永帅,吴兰芳,等.山药多糖对脑缺血再灌注损伤的保护作用机制[J].中国药理学与毒理学杂志,2021,35(9):675-676.
[34] 任 虹,刘 娟,于桂泳,等.杜仲苷对骨关节炎软骨细胞增殖和凋亡的影响及其分子机制[J].医学研究生学报,2021,34(11):1144-1149.

相似文献/References:

[1]廖 敏,谭 洁,吉 滔,等.补肾健骨汤对绝经后骨质疏松症患者骨代谢指标及性激素水平影响研究[J].陕西中医,2023,(6):726.[doi:DOI:10.3969/j.issn.1000-7369.2023.06.009]
 LIAO Min,TAN Jie,JI Tao,et al.Effect of Bushen Jiangu decoction on bone metabolic indexes and sex hormone levels in postmenopausal osteoporosis patients[J].,2023,(12):726.[doi:DOI:10.3969/j.issn.1000-7369.2023.06.009]

备注/Memo

备注/Memo:
基金项目:海南省自然科学基金资助高层次人才项目(823RC614); 海南省卫生健康行业科研项目(21A200340)
更新日期/Last Update: 2023-12-08